Liyuan Wu
- Topics
- Bladder and Urothelial Cancer Treatments (7 papers)Urinary and Genital Oncology Studies (4 papers)Hepatitis B Virus Studies (4 papers)
- Cited by
- HepatologyImmunologyCancer Research
- Journals
- Advanced MaterialsSeparation and Purification TechnologySignal Transduction and Targeted Therapy
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liyuan Wu
24 papers receiving 283 citations
Peers
Comparison fields: 5 of 61
- Immunology 91
- Molecular Biology 79
- Oncology 65
- Epidemiology 55
- Hepatology 50
Countries citing papers authored by Liyuan Wu
This map shows the geographic impact of Liyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyuan Wu more than expected).
Fields of papers citing papers by Liyuan Wu
This network shows the impact of papers produced by Liyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyuan Wu. The network helps show where Liyuan Wu may publish in the future.
Co-authorship network of co-authors of Liyuan Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Liyuan Wu. A scholar is included among the top collaborators of Liyuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyuan Wu. Liyuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 34 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | 3 | |
| 12 | 0 | |
| 13 | 0 | |
| 14 | 3 | |
| 15 | 9 | |
| 16 | 28 | |
| 17 | 2 | |
| 18 | 44 | |
| 19 | 16 | |
| 20 | 18 |
About Liyuan Wu
Liyuan Wu is a scholar working on Hepatology, Urology and Emergency Medical Services, having authored 28 papers that have together received 286 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (4 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Hepatology (50 citations), Immunology (91 citations) and Cancer Research (40 citations). Liyuan Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nianzeng Xing, Hui Shi, Fangming Wang, Feiya Yang, Shuhong Liu, Jingmin Zhao, Qinxin Zhao, Ping Zhao, Yuan Liu and Wenshu Li. Their work appears in journals such as Advanced Materials, Separation and Purification Technology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.